Copyright Reports & Markets. All rights reserved.

Global CRISPR Gene Editing Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global CRISPR Gene Editing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 gRNA Design and Vector Construction
    • 1.2.3 Cell Line and Engineering
    • 1.2.4 Screening Services
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global CRISPR Gene Editing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Agricultural
    • 1.3.3 Biomedical
    • 1.3.4 Industrial
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global CRISPR Gene Editing Market Perspective (2016-2027)
  • 2.2 CRISPR Gene Editing Growth Trends by Regions
    • 2.2.1 CRISPR Gene Editing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 CRISPR Gene Editing Historic Market Share by Regions (2016-2021)
    • 2.2.3 CRISPR Gene Editing Forecasted Market Size by Regions (2022-2027)
  • 2.3 CRISPR Gene Editing Industry Dynamic
    • 2.3.1 CRISPR Gene Editing Market Trends
    • 2.3.2 CRISPR Gene Editing Market Drivers
    • 2.3.3 CRISPR Gene Editing Market Challenges
    • 2.3.4 CRISPR Gene Editing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top CRISPR Gene Editing Players by Revenue
    • 3.1.1 Global Top CRISPR Gene Editing Players by Revenue (2016-2021)
    • 3.1.2 Global CRISPR Gene Editing Revenue Market Share by Players (2016-2021)
  • 3.2 Global CRISPR Gene Editing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by CRISPR Gene Editing Revenue
  • 3.4 Global CRISPR Gene Editing Market Concentration Ratio
    • 3.4.1 Global CRISPR Gene Editing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by CRISPR Gene Editing Revenue in 2020
  • 3.5 CRISPR Gene Editing Key Players Head office and Area Served
  • 3.6 Key Players CRISPR Gene Editing Product Solution and Service
  • 3.7 Date of Enter into CRISPR Gene Editing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR Gene Editing Breakdown Data by Type

  • 4.1 Global CRISPR Gene Editing Historic Market Size by Type (2016-2021)
  • 4.2 Global CRISPR Gene Editing Forecasted Market Size by Type (2022-2027)

5 CRISPR Gene Editing Breakdown Data by Application

  • 5.1 Global CRISPR Gene Editing Historic Market Size by Application (2016-2021)
  • 5.2 Global CRISPR Gene Editing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America CRISPR Gene Editing Market Size (2016-2027)
  • 6.2 North America CRISPR Gene Editing Market Size by Type
    • 6.2.1 North America CRISPR Gene Editing Market Size by Type (2016-2021)
    • 6.2.2 North America CRISPR Gene Editing Market Size by Type (2022-2027)
    • 6.2.3 North America CRISPR Gene Editing Market Size by Type (2016-2027)
  • 6.3 North America CRISPR Gene Editing Market Size by Application
    • 6.3.1 North America CRISPR Gene Editing Market Size by Application (2016-2021)
    • 6.3.2 North America CRISPR Gene Editing Market Size by Application (2022-2027)
    • 6.3.3 North America CRISPR Gene Editing Market Size by Application (2016-2027)
  • 6.4 North America CRISPR Gene Editing Market Size by Country
    • 6.4.1 North America CRISPR Gene Editing Market Size by Country (2016-2021)
    • 6.4.2 North America CRISPR Gene Editing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe CRISPR Gene Editing Market Size (2016-2027)
  • 7.2 Europe CRISPR Gene Editing Market Size by Type
    • 7.2.1 Europe CRISPR Gene Editing Market Size by Type (2016-2021)
    • 7.2.2 Europe CRISPR Gene Editing Market Size by Type (2022-2027)
    • 7.2.3 Europe CRISPR Gene Editing Market Size by Type (2016-2027)
  • 7.3 Europe CRISPR Gene Editing Market Size by Application
    • 7.3.1 Europe CRISPR Gene Editing Market Size by Application (2016-2021)
    • 7.3.2 Europe CRISPR Gene Editing Market Size by Application (2022-2027)
    • 7.3.3 Europe CRISPR Gene Editing Market Size by Application (2016-2027)
  • 7.4 Europe CRISPR Gene Editing Market Size by Country
    • 7.4.1 Europe CRISPR Gene Editing Market Size by Country (2016-2021)
    • 7.4.2 Europe CRISPR Gene Editing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific CRISPR Gene Editing Market Size (2016-2027)
  • 8.2 Asia-Pacific CRISPR Gene Editing Market Size by Type
    • 8.2.1 Asia-Pacific CRISPR Gene Editing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific CRISPR Gene Editing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific CRISPR Gene Editing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific CRISPR Gene Editing Market Size by Application
    • 8.3.1 Asia-Pacific CRISPR Gene Editing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific CRISPR Gene Editing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific CRISPR Gene Editing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific CRISPR Gene Editing Market Size by Region
    • 8.4.1 Asia-Pacific CRISPR Gene Editing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific CRISPR Gene Editing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America CRISPR Gene Editing Market Size (2016-2027)
  • 9.2 Latin America CRISPR Gene Editing Market Size by Type
    • 9.2.1 Latin America CRISPR Gene Editing Market Size by Type (2016-2021)
    • 9.2.2 Latin America CRISPR Gene Editing Market Size by Type (2022-2027)
    • 9.2.3 Latin America CRISPR Gene Editing Market Size by Type (2016-2027)
  • 9.3 Latin America CRISPR Gene Editing Market Size by Application
    • 9.3.1 Latin America CRISPR Gene Editing Market Size by Application (2016-2021)
    • 9.3.2 Latin America CRISPR Gene Editing Market Size by Application (2022-2027)
    • 9.3.3 Latin America CRISPR Gene Editing Market Size by Application (2016-2027)
  • 9.4 Latin America CRISPR Gene Editing Market Size by Country
    • 9.4.1 Latin America CRISPR Gene Editing Market Size by Country (2016-2021)
    • 9.4.2 Latin America CRISPR Gene Editing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa CRISPR Gene Editing Market Size (2016-2027)
  • 10.2 Middle East & Africa CRISPR Gene Editing Market Size by Type
    • 10.2.1 Middle East & Africa CRISPR Gene Editing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa CRISPR Gene Editing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa CRISPR Gene Editing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa CRISPR Gene Editing Market Size by Application
    • 10.3.1 Middle East & Africa CRISPR Gene Editing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa CRISPR Gene Editing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa CRISPR Gene Editing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa CRISPR Gene Editing Market Size by Country
    • 10.4.1 Middle East & Africa CRISPR Gene Editing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa CRISPR Gene Editing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abcam, Inc.
    • 11.1.1 Abcam, Inc. Company Details
    • 11.1.2 Abcam, Inc. Business Overview
    • 11.1.3 Abcam, Inc. CRISPR Gene Editing Introduction
    • 11.1.4 Abcam, Inc. Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.1.5 Abcam, Inc. Recent Development
  • 11.2 Applied StemCell, Inc.
    • 11.2.1 Applied StemCell, Inc. Company Details
    • 11.2.2 Applied StemCell, Inc. Business Overview
    • 11.2.3 Applied StemCell, Inc. CRISPR Gene Editing Introduction
    • 11.2.4 Applied StemCell, Inc. Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.2.5 Applied StemCell, Inc. Recent Development
  • 11.3 Cellecta, Inc.
    • 11.3.1 Cellecta, Inc. Company Details
    • 11.3.2 Cellecta, Inc. Business Overview
    • 11.3.3 Cellecta, Inc. CRISPR Gene Editing Introduction
    • 11.3.4 Cellecta, Inc. Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.3.5 Cellecta, Inc. Recent Development
  • 11.4 CRISPR Therapeutics AG
    • 11.4.1 CRISPR Therapeutics AG Company Details
    • 11.4.2 CRISPR Therapeutics AG Business Overview
    • 11.4.3 CRISPR Therapeutics AG CRISPR Gene Editing Introduction
    • 11.4.4 CRISPR Therapeutics AG Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.4.5 CRISPR Therapeutics AG Recent Development
  • 11.5 GeneCopoeia, Inc.
    • 11.5.1 GeneCopoeia, Inc. Company Details
    • 11.5.2 GeneCopoeia, Inc. Business Overview
    • 11.5.3 GeneCopoeia, Inc. CRISPR Gene Editing Introduction
    • 11.5.4 GeneCopoeia, Inc. Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.5.5 GeneCopoeia, Inc. Recent Development
  • 11.6 GenScript Biotech Corporation
    • 11.6.1 GenScript Biotech Corporation Company Details
    • 11.6.2 GenScript Biotech Corporation Business Overview
    • 11.6.3 GenScript Biotech Corporation CRISPR Gene Editing Introduction
    • 11.6.4 GenScript Biotech Corporation Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.6.5 GenScript Biotech Corporation Recent Development
  • 11.7 Horizon Discovery Group PLC
    • 11.7.1 Horizon Discovery Group PLC Company Details
    • 11.7.2 Horizon Discovery Group PLC Business Overview
    • 11.7.3 Horizon Discovery Group PLC CRISPR Gene Editing Introduction
    • 11.7.4 Horizon Discovery Group PLC Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.7.5 Horizon Discovery Group PLC Recent Development
  • 11.8 Integrated DNA Technologies, Inc.
    • 11.8.1 Integrated DNA Technologies, Inc. Company Details
    • 11.8.2 Integrated DNA Technologies, Inc. Business Overview
    • 11.8.3 Integrated DNA Technologies, Inc. CRISPR Gene Editing Introduction
    • 11.8.4 Integrated DNA Technologies, Inc. Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.8.5 Integrated DNA Technologies, Inc. Recent Development
  • 11.9 Merck KGaA
    • 11.9.1 Merck KGaA Company Details
    • 11.9.2 Merck KGaA Business Overview
    • 11.9.3 Merck KGaA CRISPR Gene Editing Introduction
    • 11.9.4 Merck KGaA Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.9.5 Merck KGaA Recent Development
  • 11.10 New England Biolabs, Inc.
    • 11.10.1 New England Biolabs, Inc. Company Details
    • 11.10.2 New England Biolabs, Inc. Business Overview
    • 11.10.3 New England Biolabs, Inc. CRISPR Gene Editing Introduction
    • 11.10.4 New England Biolabs, Inc. Revenue in CRISPR Gene Editing Business (2016-2021)
    • 11.10.5 New England Biolabs, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global CRISPR Gene Editing Scope and Market Size
    CRISPR Gene Editing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR Gene Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    gRNA Design and Vector Construction
    Cell Line and Engineering
    Screening Services
    Others

    Segment by Application
    Agricultural
    Biomedical
    Industrial
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Abcam, Inc.
    Applied StemCell, Inc.
    Cellecta, Inc.
    CRISPR Therapeutics AG
    GeneCopoeia, Inc.
    GenScript Biotech Corporation
    Horizon Discovery Group PLC
    Integrated DNA Technologies, Inc.
    Merck KGaA
    New England Biolabs, Inc.

    Buy now